the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Philippines detects 2 more new cases of Mpox

MANILA: The Philippines has detected two additional new cases of monkeypox (Mpox), bringing the number of active Mpox cases in the country to three, reported Xinhua, quoting the Department of Health (DOH) on Monday.

DOH spokesperson Assistant Secretary Albert Domingo said the new cases include a 37-year-old male and a 32-year-old male from Metro Manila. The 37-year-old is currently confined at a hospital, while the 32-year-old is staying at home waiting for a confirmatory test result of a skin sample.

“Both have MPXV Clade II, which is the milder form of the Mpox virus,“ Domingo said.

Domingo said the DOH cannot yet determine any epidemiologic linkages of the two new cases to the first active case of 2024, a 33-year-old male detected on Monday last week.

With the detection of new Mpox cases, the Philippines has now tallied 12 cases since July 2022.

“Nine cases have long recovered since 2023. Three are active cases waiting for symptoms to resolve,“ Domingo said.

“We continue to see local transmission of Mpox clade II here in the Philippines, particularly in Metro Manila,“ Philippine Health Secretary Teodoro Herbosa said.

Mpox can be transmitted through close and intimate contact with the infected.

The common symptoms of Mpox are a rash, fever, headache, muscle aches, back pain, low energy, and swollen lymph nodes.

On Aug. 14, the World Health Organisation declared the Mpox outbreak “a public health emergency of international concern.” – Bernama, Xinhua

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings